Recently, a daily oral GLP-1 option was approved by the US Food and Drug Administration (FDA), 2 expanding how these medications may be administered and offering another avenue for those who were previously apprehensive about injections.* Clinical trials have shown meaningful weight loss outcomes with both oral and injectable formulations, though real-world use may vary
As a whole grain and an excellent source of fibre, it can help lower the risk of acid reflux
2020 , 8867875 (2020) Cordeanu, E.M., Qureshi, A.W., Mroueh, A., Mazzucotelli, J.P., Stephan, D., Schini-Kerth, V.: GLP1 receptor agonists exhibit antioxidant and anti-inflammatory properties in human heart tissue via the canonical GLP1 receptor expression through a AMPK-mediated pathway
Academic Press, San Diego Brown MF (2012) Curvature forces in membrane lipidprotein interactions